When 15-year-old Anna Hankins accepted the title of Miss Amazing in Chicago, the Mississippi teen was beaming not only because of the award, but also because of the opportunity to raise awareness ...

Prader-Willi Syndrome affects thousands of children in the United States, yet is relatively unknown to the general population. This genetic condition, resulting from an abnormality on the 15th ...

Haley Kavrell, 17, who must cope with Prader-Willi syndrome, which causes her to feel constant hunger, picks basil at her home in Davis late last month. Renée C. Byer [email protected] After receiving ...

An Australian study reveals that people with the rare genetic disorder known as Prader-Willi Syndrome may have an impaired autonomic nervous system. This discovery opens up a new way of looking at the ...

MINNEAPOLIS (WCCO) --No parent wants their child to suffer from hunger pains, but for one Twin Cities family, that's a constant struggle. Two-year-old Nick Joncas never feels full. He has a disease ...

Stem cell researchers have reversed Prader-Willi syndrome in brain cells growing in the lab. The discovery provides clues that could lead to a treatment for Prader-Willi, a genetic disorder that ...

Andrea Prader and Heinrich Willi, two Swiss pediatricians, and Alexis Labhart, an internist, first described Prader-Labhart-Willi Syndrome in 1956. Prader was an influential figure in European ...

The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) submitted by Soleno Therapeutics for diazoxide choline prolonged-release tablets, aimed at treating ...

A central characteristic of people with Prader-Willi Syndrome (PWS) is an apparent insatiable appetite leading to severe overeating and the potential for marked obesity and associated serious health ...

The FDA granted orphan drug designation to an investigational drug for the treatment of Prader-Willi syndrome, according to an industry press release. Tesomet (Saniona) is an investigational, ...

CHICAGO, Nov. 18, 2019 /PRNewswire/ -- Levo Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for LV-101 (intranasal carbetocin) ...